gene mutations have been demonstrated as the cause of stress-induced childhood-onset neurodegeneration with variable ataxia and seizures (CONDSIAS), an autosomal recessive genetic disorder characterized by an abnormal gait, intellectual disability, seizures, ataxia, other nervous system degenerative diseases, and axonal sensorimotor neuropathy. Since first reported in 2018, ADP-ribosylhydrolase like 2 () gene mutations in previous cases were all diallelic homozygous. Here, we report a case of CONDSIAS with a novel compound heterozygous mutation in the gene. This patient is presented with autonomic nervous dysfunction manifested as polyuria, gastrointestinal disturbance, and sinus arrhythmia, which may be considered as new clinical manifestations in addition to the above classical manifestations. Muscle biopsy revealed myogenic lesions, which is a previously unreported feature.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874324PMC
http://dx.doi.org/10.3389/fneur.2022.807291DOI Listing

Publication Analysis

Top Keywords

stress-induced childhood-onset
8
childhood-onset neurodegeneration
8
novel compound
8
compound heterozygous
8
heterozygous mutation
8
mutation gene
8
gene mutations
8
case report
4
report stress-induced
4
neurodegeneration ataxia-seizures
4

Similar Publications

Article Synopsis
  • ADP-ribosylation is a process where ADP-ribose units are transferred from NAD+ to proteins, and its dysregulation is linked to neurodegenerative diseases.
  • A study used genetic testing on two siblings suffering from developmental issues, seizures, and muscle weakness, identifying a new variant in the ADPRS gene that contributes to their diagnosis of childhood-onset neurodegeneration with stress-induced ataxia and seizures (CONDSIAS).
  • The identified genetic variant affects the protein ARH3, leading to its instability, improper localization, and accumulation of harmful compounds, helping to explain the disease's mechanisms and the importance of ARH3 in maintaining nervous system health.
View Article and Find Full Text PDF

Novel heterozygous variant of causes pathogenic variation in CONDSIAS.

Heliyon

July 2024

Department of Neurology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China.

Adprhl2 (OMIM: 610624) mutation associated stress-induced childhood-onset neurodegeneration with variable ataxia and seizures (CONDSIAS, OMIM: 618170) is a sporadic neurodegenerative disease with poor prognosis. encodes ADP-ribosylhydrolase 3 (ARH3), which participates in ADP-ribosylation to remove poly-ADP ribose (PAR). We found a new compound heterozygous mutation in the gene c.

View Article and Find Full Text PDF

Purpose: ADP-ribosylation is a post-translational modification involving the transfer of one or more ADP-ribose units from NAD+ to target proteins. Dysregulation of ADP-ribosylation is implicated in neurodegenerative diseases. Here we report a novel homozygous variant in the gene (c.

View Article and Find Full Text PDF

is involved in posttranslational modification and is known to have a role in physiological functions such as cell signaling, DNA repair, gene control, cell death, and response to stress. Recently, a group of neurological disorders due to variants is described, characterized by childhood-onset, stress-induced variable movement disorders, neuropathy, seizures, and neurodegenerative course. We present the diagnostic pathway of two pediatric patients with episodic dystonia and ataxia, who later had a neurodegenerative course complicated by central hypoventilation syndrome due to the same homozygous variant.

View Article and Find Full Text PDF

Sustained OMA1-mediated integrated stress response is beneficial for spastic ataxia type 5.

Brain

March 2024

Mitochondrial Dysfunctions in Neurodegeneration Unit, Division of Neuroscience, IRCCS Ospedale San Raffaele, 20132 Milan, Italy.

AFG3L2 is a mitochondrial protease exerting protein quality control in the inner mitochondrial membrane. Heterozygous AFG3L2 mutations cause spinocerebellar ataxia type 28 (SCA28) or dominant optic atrophy type 12 (DOA12), while biallelic AFG3L2 mutations result in the rare and severe spastic ataxia type 5 (SPAX5). The clinical spectrum of SPAX5 includes childhood-onset cerebellar ataxia, spasticity, dystonia and myoclonic epilepsy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!